These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 1433014

  • 1. Fibronectin fragments in osteoarthritic synovial fluid.
    Xie DL, Meyers R, Homandberg GA.
    J Rheumatol; 1992 Sep; 19(9):1448-52. PubMed ID: 1433014
    [Abstract] [Full Text] [Related]

  • 2. Presence of ED-A containing fibronectin in human articular cartilage from patients with osteoarthritis and rheumatoid arthritis.
    Chevalier X, Claudepierre P, Groult N, Zardi L, Hornebeck W.
    J Rheumatol; 1996 Jun; 23(6):1022-30. PubMed ID: 8782135
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Concentration and size distribution of insulin-like growth factor-I in human normal and osteoarthritic synovial fluid and cartilage.
    Schneiderman R, Rosenberg N, Hiss J, Lee P, Liu F, Hintz RL, Maroudas A.
    Arch Biochem Biophys; 1995 Dec 01; 324(1):173-88. PubMed ID: 7503553
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beneficial effects of intermittent fluid pressure of low physiological magnitude on cartilage and inflammation in osteoarthritis. An in vitro study.
    van Valburg AA, van Roy HL, Lafeber FP, Bijlsma JW.
    J Rheumatol; 1998 Mar 01; 25(3):515-20. PubMed ID: 9517773
    [Abstract] [Full Text] [Related]

  • 7. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M, Kuboki T, Kojima S, Fujisawa T, Hattori T, Takigawa M, Yamashita A.
    J Orofac Pain; 2000 Mar 01; 14(1):20-30. PubMed ID: 11203734
    [Abstract] [Full Text] [Related]

  • 8. Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid.
    Shinmei M, Kobayashi T, Yoshihara Y, Samura A.
    J Rheumatol Suppl; 1995 Feb 01; 43():78-81. PubMed ID: 7752146
    [Abstract] [Full Text] [Related]

  • 9. Accelerated clearance of albumin from the osteoarthritic knee: implications for interpretation of concentrations of "cartilage markers" in synovial fluid.
    Myers SL, O'Connor BL, Brandt KD.
    J Rheumatol; 1996 Oct 01; 23(10):1744-8. PubMed ID: 8895152
    [Abstract] [Full Text] [Related]

  • 10. The serine protease inhibitor trappin-2 is present in cartilage and synovial fluid in osteoarthritis.
    Jaovisidha K, Etim A, Yamakawa K, Masuda I, Gohr CM, Wakim BT, Boonapatcharoen N, Ninomiya J, Rosenthal AK.
    J Rheumatol; 2006 Feb 01; 33(2):318-25. PubMed ID: 16465664
    [Abstract] [Full Text] [Related]

  • 11. Fibronectin as a marker for osteoarthritis.
    Lust G, Burton-Wurster N, Leipold H.
    J Rheumatol; 1987 May 01; 14 Spec No():28-9. PubMed ID: 3625673
    [Abstract] [Full Text] [Related]

  • 12. Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments.
    Homandberg GA.
    Front Biosci; 1999 Oct 15; 4():D713-30. PubMed ID: 10525477
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH, Poilvache P, Van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ.
    Arthritis Rheum; 2000 Feb 15; 43(2):281-8. PubMed ID: 10693867
    [Abstract] [Full Text] [Related]

  • 15. Degenerated human articular cartilage at autopsy represents preclinical osteoarthritic cartilage: comparison with clinically defined osteoarthritic cartilage.
    van Valburg AA, Wenting MJ, Beekman B, Te Koppele JM, Lafeber FP, Bijlsma JW.
    J Rheumatol; 1997 Feb 15; 24(2):358-64. PubMed ID: 9034997
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS, Ionescu M, Jugessur H, Poole AR.
    Arthritis Rheum; 1999 Mar 15; 42(3):534-44. PubMed ID: 10088777
    [Abstract] [Full Text] [Related]

  • 19. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, Singer II, Donatelli SA, Weidner JR, Williams HR, Mumford RA, Lohmander LS.
    J Clin Invest; 1997 Jul 01; 100(1):93-106. PubMed ID: 9202061
    [Abstract] [Full Text] [Related]

  • 20. Differential adherence of osteoarthritis and rheumatoid arthritis synovial fibroblasts to cartilage and bone matrix proteins and its implication for osteoarthritis pathogenesis.
    Schedel J, Wenglén C, Distler O, Müller-Ladner U, Schölmerich J, Heinegård D, Krenn V.
    Scand J Immunol; 2004 Nov 01; 60(5):514-23. PubMed ID: 15541045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.